These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4961731)

  • 21. Microbiological relevance and clinical potential of ampicillin-cloxacillin synergism.
    Barrelet L; Regamey C; Waldvogel FA
    Biomedicine; 1977 May; 26(3):169-75. PubMed ID: 329905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transmissible resistance toward polysynthetic penicillins].
    Datta N
    Antibiotiki; 1971 Jun; 16(6):523-5. PubMed ID: 5000147
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental cystitis, a modell of chronic bacteriuria in rats (author's transl)].
    Prat V; Mohr HJ; Hatala M; Konickova L
    Beitr Pathol; 1973 Oct; 150(1):55-69. PubMed ID: 4203397
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences in treatment of Pyocyaneus infections of the urinary tract by carbenicillin].
    Gritz K; Naumann P
    Arzneimittelforschung; 1969 Aug; 19(8):1237-41. PubMed ID: 4980238
    [No Abstract]   [Full Text] [Related]  

  • 25. [Carbenicillin. Experimental studies on the antibacterial activity and clinical pharmacology].
    Naumann P; Kempf J
    Arzneimittelforschung; 1969 Aug; 19(8):1222-33. PubMed ID: 4980237
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic.
    Wise R; Reeves DS
    Chemotherapy; 1974; 20(1):45-51. PubMed ID: 4210893
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined effect of semi-synthetic penicillins (ampicillin and oxacillin) on clinical strains of gram-positive and gram-negative microorganisms].
    Navashin SM; Petrova MA; Chavdarova VB
    Antibiotiki; 1969 Nov; 14(11):1006-11. PubMed ID: 4985088
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admission.
    Tacconelli E; D'Agata EM; Karchmer AW
    Clin Infect Dis; 2003 Sep; 37(5):644-9. PubMed ID: 12942394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characteristics of current antibiotic therapy].
    Navashin SM; Fomina IP
    Klin Med (Mosk); 1979 Jul; 57(7):10-23. PubMed ID: 113612
    [No Abstract]   [Full Text] [Related]  

  • 30. [Factors, affecting penicillin therapy].
    Knudsen ET
    Antibiotiki; 1971 Jun; 16(6):525-9. PubMed ID: 5112487
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of selected bacterial infections with "Polfa" penicillin Hx].
    Janeczko J; Pokrzywnicka T; Olejnik Z; Narebski J; Dziubek Z; Babiuch L
    Pol Tyg Lek; 1982 Dec; 37(50):1501-4. PubMed ID: 6306622
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes in patterns and resistances of bacteria from 731 patients with bacteremia in 11 years].
    Xin J; Xiang Y; Zhang J
    Zhonghua Yi Xue Za Zhi; 1997 May; 77(5):332-5. PubMed ID: 9772485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro evaluation of the combined effect of polysynthetic penicillins on gram-negative microorganisms].
    Ved'mina EA; Vasina TA
    Antibiotiki; 1970 Aug; 15(8):695-9. PubMed ID: 4992774
    [No Abstract]   [Full Text] [Related]  

  • 34. [Modern aspects of the treatment of Pseudomonas aeruginosa infection].
    Rozhavin MA
    Antibiotiki; 1980 Apr; 25(4):303-7. PubMed ID: 6768339
    [No Abstract]   [Full Text] [Related]  

  • 35. Tobramycin: clinical and microbiological evaluation.
    Schoutens E; Vanderlinden MP; Yourassowsky E
    Int J Clin Pharmacol; 1973 Nov; 8(3):207-15. PubMed ID: 4589328
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro action of combinations of antimicrobial agents and EDTA-tromethamine on Pseudomonas aeruginosa.
    Wooley RE; Jones MS; Gilbert JP; Shotts EB
    Am J Vet Res; 1983 Aug; 44(8):1521-4. PubMed ID: 6414345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of combinations of antibacterial preparations on resistant strains of pyelonephritis agents].
    Sukhodol'skaia AE; Chaĭkovskaia VL
    Antibiotiki; 1974 Jul; 19(7):630-3. PubMed ID: 4618771
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention and drug therapy of penicillin resistant gram-negative rod bacterial infections].
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):285-8. PubMed ID: 2185324
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Laboratory studies and therapeutic effect on respiratory infections of a combined preparation of ampicillin and cloxacillin (author's transl)].
    Nasu M; Iwanaga M; Saito A; Tsutsumi T; Hirota M
    Jpn J Antibiot; 1975 Jun; 28(3):345-52. PubMed ID: 807759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.